1-10 of 82 results
Cyber resilience and incident response in healthcare
Cyber incidents are disproportionately frequent in the healthcare sector—and their consequences are often more severe. The potentially life-threatening risk to patient care means that healthcare ...
Allens advises on acquisition financing of the Jones Radiology business
Allens advised the Commonwealth Bank of Australia (CBA) – the sole funder on the transaction – which involved the acquisition of a 49% shareholding previously held by I-MED Radiology. Jones ...
PE Horizons 2025: the year to get creative
Key PE trends from 2024 and what these mean for the Australian and global markets in 2025. ...
Five things to know about investment in healthtech
The use of technology to improve or create efficiencies in the delivery of healthcare services, and to progress precision/preventative models is continuing to drive investment in Healthtech. Here are our 'top 5' tips for investing in Healthtech. ...
Allens advises BDT & MSD on $1.6bn investment in DBG Health
The deal includes a potential follow-on investment of up to $1 billion, representing one of the largest private, founder-led transactions in Australia. Allens collaborated with Sidley Austin in New ...
Patent term extensions under siege: a new era of challenges for pharmaceutical patentees
A recent Federal Court decision has struck down a patent term extension granted to Novartis for its blockbuster heart failure drug Entresto. The decision in Novartis AG v Pharmacor Pty Limited follows a recent trend of successful challenges by generic pharmaceutical companies. ...
Linklaters Insights: Novel Coronavirus - practice guide of significant commercial and legal issues
The recent outbreak of the novel coronavirus is causing disruption across greater China and the region. This cross-practice guide from our colleagues at Linklaters highlights key issues that may affect business operations in the current environment. ...
Using third party brands in video games: issues and opportunities
One of the emerging battlegrounds for brand owners is video games, particularly with the growth of virtual reality applications. A recent claim made in the US illustrates how having your brand featured in a video game can be a problem - but depending on the circumstances, it could also present a com ...
Audio: D'Arcy v Myriad: The High Court rules on gene patenting
Allens Partner Dr Trevor Davies discusses why the High Court overturned the decision and what it means for the biotech industry ...
Not quite business as usual - IP Australia takes pragmatic view of Myriad
IP Australia has taken a pragmatic approach to the Myriad decision that will give comfort to Australias biotechnology industry and research organisations that they can continue to carry out biological RD and be able to obtain patent protection for innovation in Australia Partner Dr Trevor Davies ...